• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Bye-Bye China?

    Decentralized Trials Fuel AI Revolution in Clinical Research

    Self-Medication: Flexibility for Patients and Drug Manufacturers

    The Single-Use Mixing Landscape: Evaluating Your Options

    DCAT President Talks COVID-19, Drug Manufacturing and Innovation
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Frontage Bolsters Clinical Services Capabilities

    Sanofi Unveils EUROAPI as Name of New European API Company

    Thermo Fisher Buys Novasep's Viral Vector Manufacturing Biz

    Precision Medicine Group Acquires Project Farma

    Charles River Partners with JADE
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Sanofi Unveils EUROAPI as Name of New European API Company

    Precision Medicine Group Acquires Project Farma

    Cytiva Delivers Modular Biologics Factory to Lonza

    Fujifilm, CABIM Get $76M Funding for Mfg. and Innovation Center

    LSNE Expands Fill Finish and Lyophilization Ops
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Catalent Acquires Acorda’s INBRIJA Manufacturing Operations

    Varcode, PL Developments Form Strategic ‘Smart Tag’ Pact

    COVID-19 Vaccine Distribution: The Air Cargo Industry’s Greatest Challenge

    Thermo Fisher Expands Clinical Supply Services in Europe

    Schreiner MediPharm Joins DoseID Consortium
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Virtual Clinical Trials: The Future of Dermatology Studies

    Frontage Bolsters Clinical Services Capabilities

    Thermo Fisher Buys Novasep's Viral Vector Manufacturing Biz

    Precision Medicine Group Acquires Project Farma

    Cytiva Delivers Modular Biologics Factory to Lonza
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Gene Therapy Co. Selects ValGenesis' SaaS Platform

    The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021

    Samsung Biologics Adopts Veeva Vault QMS to Unify Quality Management

    CDMO Cognate BioServices Teams Up with L7 Informatics

    The Wasdell Group Earns ISO 13485 Certification
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Emergent BioSolutions

    Baxter BioPharma Solutions

    Flow Sciences

    Reed-Lane

    Adare Pharma Solutions
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Alcami

    Adare Pharma Solutions

    Flow Sciences

    Reed-Lane

    Syngene
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • Podcasts
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Back Page

    Biopharma Nomenclature

    Citizen petition requests biopharmaceutical names and information be disclosed by FDA

    Related CONTENT
    • Samsung Biologics Names John Rim as President and CEO
    • Bye-Bye China?
    • Mogene
    • Frontida BioPharm Names Steven Roese as Vice President, Quality
    • Avomeen Names SVP of Lab Operations
    Ronald A. Rader, Biotechnology Information Institute09.05.13
    The Biotechnology Information Institute (of which I am president) has filed a Citizen Petition requesting that FDA assign both unique and biosimilar/(bio)generic-type (or class) names (and/or other identifiers) to approved biologic products and their active agents, along with disclosures of sufficient public information to enable an adequate understanding of product identity (what the products/agents are, which is largely dependent on their composition, bioprocessing and quality-related (CMC) aspects). The petition also requests information regarding nomenclature and product identity (CMC) aspects be disclosed prior to approval and discussed as part public advisory committee meetings. Further information on the petition is available at www.biopharmacopeia.com.

    Biopharma products are each unique and differentiated on the basis of their composition, bioprocessing and quality-related (CMC) aspects, with any significant CMC changes defining a new product and thus requiring a new approval, either supplemental or full BLA. This petition requests FDA assign names (and/or other identifiers) to products and agents upon impending approval. The petition also requests: unique names/identifiers and related information disclosures concerning supplemental BLA changes in products/agents (tracking of product drift); and that any nomenclature for names/identifiers be coherent, science/product/entity-based and unencumbered by legacy regulatory requirements.

    Despite biopharmaceuticals being the most complex of all consumer products, these products lack both unique and generic-type descriptive or otherwise useful authoritative non-proprietary (publically-usable) names! Currently there are no non-proprietary names (no nomenclature systems) for approved biologics that reflect the nature of the products (and active agents), what they are, with current non-proprietary names highly constrained by regulatory requirements. The official (established/compendial/USAN) non-proprietary names assigned by FDA, widely used for marketing and prescriptions, are insufficiently descriptive (short, for writing prescriptions), are not linked to any product/agent descriptions (are totally undefined), and do not change as the products/agents change (track product drift). Further, these names are fully ambiguous, with the same names, e.g., rituximab, used as both the name for the product and the active agent, with those encountering the names having to guess by context whether a name is referring to a product or agent. This may work well enough for generic small molecule drugs, but not for biopharmaceuticals — which are defined by their unique bioprocessing — particularly in the context of hundreds of biosimilars set to enter the U.S. market.

    The petition has nothing to do with official names for these products. These have been the subject of years of yet-to-be-resolved controversies over what type official names FDA should assign to biosimilars, e.g., unique or (bio)generic names. Otherwise, biosimilar/(bio)generic or class names for biologic products and active agents simply do not exist yet.

    It is very common for FDA review information related to product composition, bioprocessing and CMC aspects to have been 100% redacted (censored), as illustrated with multiple products in an appendix to the petition. In fact, the few descriptive sentences included in product inserts are often more informative than the cumulative product approval-related documentation available from FDA! The petition seeks more substantive and useful product/agent-related disclosures in review-related public documentations. Currently, lacking both useable names/ identifiers and the most basic authoritative descriptive information, biopharmaceuticals risk being tagged as “Frankenpharma-ceuticals,” as has happened with GMO food products.

    The petition also requests that FDA’s proposed names and product-defining information, including CMC aspects, be discussed at public advisory committee meetings. Neither the public documents disclosed prior to these meetings nor the meetings themselves now include discussion of CMC-related aspects, which are much more a determinant and critical for an understanding of product safety than the minutiae of clinical studies, which now dominate these meetings.

    No matter what names/identifiers FDA assigns to biologics, expert input and representation of diverse interests (uses/user communities) should be an integral part of developing names — the candidates for selection by FDA and other names for other uses/user communities. Regrettably, the U.S. biopharma industry lacks its own dedicated trade association that normally would be involved hands-on with such issues. The petitioner has proposed the U.S. Biopharmacopeia™ Registry of Biopharmaceutical Products project to propose candidate unique and non-unique names for biopharmaceutical products/ agents suitable for selective adoption by diverse user communities, including regulatory agencies, formularies, reference sources, public use, etc.; and post a public website providing this information. The Biopharmacopeia project might function similar to the CTFA/PCPA (cosmetics trade association) Dictionary project, which for nearly 40 years has involved an industry-based committee proposing cosmetic ingredient names to FDA, with these almost always adopted for official product labeling.


    Ronald. A. Rader is president, Biotechnology Information Institute, and the author/publisher of BIOPHARMA: Biopharma-ceutical Products in the U.S. and European Markets (biopharma.com). For further information or to lend your support to the petition, contact Mr. Rader at biotech@biopharma.com.
    Related Searches
    • CMC
    • Biopharma
    • Biosimilars
    Suggested For You
    Samsung Biologics Names John Rim as President and CEO Samsung Biologics Names John Rim as President and CEO
    Bye-Bye China? Bye-Bye China?
    Mogene Mogene
    Frontida BioPharm Names Steven Roese as Vice President, Quality Frontida BioPharm Names Steven Roese as Vice President, Quality
    Avomeen Names SVP of Lab Operations Avomeen Names SVP of Lab Operations
    Metrics Contract Services Expands Business Development Team Metrics Contract Services Expands Business Development Team
    Recro Gainesville Expands Mfg. Capabilities Recro Gainesville Expands Mfg. Capabilities
    Diverse Products And Technologies Delivered Diverse Products And Technologies Delivered
    PCI Biotech, RXi Pharma Extend Research Collaboration PCI Biotech, RXi Pharma Extend Research Collaboration
    PPD Expands Vaccine Development Lab PPD Expands Vaccine Development Lab
    Sartorius Partners with Nova Biomedical Sartorius Partners with Nova Biomedical
    Kemwell Provides Services for U.S. Trial Kemwell Provides Services for U.S. Trial
    UPM Celebrates 100-Years of Mfg. at Tennessee Site UPM Celebrates 100-Years of Mfg. at Tennessee Site
    DelMar Collaborates with PRA Health Sciences DelMar Collaborates with PRA Health Sciences
    INC Research, inVentiv Health to Merge INC Research, inVentiv Health to Merge

    Related Back Page

    • Biologics, Proteins, Vaccines | Biosimilars | R&D
      The Global Biotech Boom

      The Global Biotech Boom

      How an industry grew to lead health care innovation and how CROs are adapting to meet their needs.
      Davide Garrisi, PPD Biotech 09.09.20

    • Biologics, Proteins, Vaccines | Biosimilars
      Biotech Booms in the Yangtze River Valley

      Biotech Booms in the Yangtze River Valley

      A look at forces shaping the course of biotech growth in China
      Daniel Burch, M.D., Global Medical Officer, PPD Biotech 05.07.19

    • Biologics, Proteins, Vaccines | Biosimilars
      Biogenerics Progress

      Biogenerics Progress

      Generic makers target big forays into major markets
      S. Harachand, Contributing Editor 06.12.18


    • Analytical Services | Biosimilars

      How to Build Better Proteins

      Advancing the next generation of biologics
      Aileen Ruff, Catalent 03.09.16

    • Biosimilars | Validation

      Biosimilars on the Horizon

      The emerging biosimilar market is ripe with opportunities for CROs and CMOs to imprint their brand
      Cliff Echols, Bluebox Research 10.07.15

    Trending
    • Catalent Acquires Acorda’s INBRIJA Manufacturing Operations
    • Fujifilm To Invest $2B In US Manufacturing Site
    • Baxter, Novavax Ink Sterile Manufacturing Agreement
    • Precision Medicine Group Acquires Project Farma
    • Roche Canada To Invest $500M To Create 500 Jobs In Ontario
    Breaking News
    • Frontage Bolsters Clinical Services Capabilities
    • Sanofi Unveils EUROAPI as Name of New European API Company
    • Thermo Fisher Buys Novasep's Viral Vector Manufacturing Biz
    • Precision Medicine Group Acquires Project Farma
    • Charles River Partners with JADE
    View Breaking News >
    CURRENT ISSUE

    November/December 2020

    • Modeling Process Safety Workflows in Pharmaceutical Manufacturing Scale-Up
    • Ensuring Quality During the Transfer and Scale Up of Rx Drugs
    • Inspecting the Unexpected
    • Cold Chain Trends
    • Catering for the Complex
    • Biopharma Contract Manufacturing: Robust Growth Ahead
    • DCAT President Talks COVID-19, Drug Manufacturing and Innovation
    • The Single-Use Mixing Landscape: Evaluating Your Options
    • Self-Medication: Flexibility for Patients and Drug Manufacturers
    • Decentralized Trials Fuel AI Revolution in Clinical Research
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    NIH Study Identifies Antibacterial Properties in Taurine
    NSF Begins New Certification Program
    Eriocitrin Shown to Have Metabolic Benefits in Recent Study
    Coatings World

    Latest Breaking News From Coatings World

    Zeppelin Acquires MTI Mischtechnik
    Ezio Braggio Joins ChemQuest Europe
    IFS Coatings Announce Carbon Offset Program
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Optimize EP Launches CaRM Cardiac Device Data Management Platform
    U.S. TAVR Market Projected to Reach Nearly $5 Billion by 2030
    FDA Clears Canon Medical's Compressed SPEEDER for 3D Exams on 1.5T MR
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Frontage Bolsters Clinical Services Capabilities
    Sanofi Unveils EUROAPI as Name of New European API Company
    Thermo Fisher Buys Novasep's Viral Vector Manufacturing Biz
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Neenah to Host Packaging Webinar for Printers
    W.S. Badger is Named a ‘150 Top Impact Company’
    Mana Products, Meiyume and RPG Form The Vertical Beauty Alliance
    Happi

    Latest Breaking News From Happi

    Amyris Named a Top Social & Environmental Impact Company
    L'Oréal Bans Animal Hair in Brushes
    Ashland Launches Antaron ECo Gel
    Ink World

    Latest Breaking News From Ink World

    dar-tech, inc. Becomes U.S. Midwestern Distributor for ZS Interpolymer
    Techkon USA, Konica Minolta Partner
    Alon Bar-Shany Appointed Chairman of Highcon Board
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Exhibitor registration opens for virtual.drupa
    FTA planning in-person Forum & INFOFLEX
    Fortis Solutions Group achieves SGP certification
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Shemesh Adds U.S. Headquarters
    TZMO USA, Special Needs Group Form Partnership
    BAHP Announces 2021 Officers, Board of Directors
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Rapid Recovery Protocol Can Lead to Increased Range of Motion After TKA
    Boston Scientific Releases WaveWriter Alpha Spinal Cord Stimulators in U.S.
    New Chief Clinical Officer on Board at IncludeHealth
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Roadsimple Modernizes Warehouse Ops with Zebra Technologies
    Toppan Announces 2050 Environmental Vision
    SOI Industry Consortium Joins SEMI as Strategic Association Partner

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login